Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
16 Cards in this Set
- Front
- Back
An integral component of respect for person is ___________.
|
autonomoy
|
|
Duty not to harm others is referred to as __________.
|
beneficence
|
|
Objectve allocation of social benefits and burdens is included in the principle of _____________.
|
justice
|
|
Few potential drugs are actually used in clinical situations based on the findings of the research and developmental process. The number is approximately 1 in how many?
|
1 in 10,000
|
|
Identification of the safe therapeutic dose and drug-related abnormal changes in animal organs are objectives in _______________.
|
toxicity screening
|
|
A multidisciplinary team ensures that data will answer the clinical questions in which phase of human experimentation?
|
II (2)
|
|
Long-term use of a drug is addressed in which phase of human experimentation
|
IV (4)
|
|
A standard for the many aspects of clinical trials is ______________.
|
Good Clinical Practice (GCP)
|
|
An integral component of respect for person is ___________.
|
autonomoy
|
|
Duty not to harm others is referred to as __________.
|
beneficence
|
|
Objectve allocation of social benefits and burdens is included in the principle of _____________.
|
justice
|
|
Few potential drugs are actually used in clinical situations based on the findings of the research and developmental process. The number is approximately 1 in how many?
|
1 in 10,000
|
|
Identification of the safe therapeutic dose and drug-related abnormal changes in animal organs are objectives in _______________.
|
toxicity screening
|
|
A multidisciplinary team ensures that data will answer the clinical questions in which phase of human experimentation?
|
II (2)
|
|
Long-term use of a drug is addressed in which phase of human experimentation
|
IV (4)
|
|
A standard for the many aspects of clinical trials is ______________.
|
Good Clinical Practice (GCP)
|